21 May 2013
Keywords: indevus, files, oab, drug, trospium, usa, pharmaceuticals
Article | 05 May 2003
Indevus Pharmaceuticals has filed for approval of its overactive bladdertreatment, trospium, in the USA. The company also unveiled new Phase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2003
20 May 2013
© 2013 thepharmaletter.com